Immunogenicity and booster efficacy of pre-exposure rabies vaccination

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 11, 2009, Pages 1159-1164

  Strady, C ^a   Andreoletti, L ^b   Baumard, S ^a   Servettaz, A ^a   Jaussaud, R ^a   Strady, A ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Booster; France; Immunogenicity; Rabies; Rabies vaccines; Vaccination

Indexed keywords

RABIES VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; FOLLOW UP; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MONITORING; RABIES; SCHOOL CHILD; SEROLOGY; VACCINATION;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, VIRAL; CHILD; FEMALE; HUMANS; IMMUNIZATION; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RABIES; RABIES VACCINES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 70349826905     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2009.03.007     Document Type: Article

References (24)

1. WHO. Expert consultation on rabies. First report. Geneva: World Health Organization; 2005, Technical Report Series No. 931.
2. Dodet B., and Asian Rabies Expert Bureau (AREB). An important date in rabies history. Vaccine 25 (2007) 8647-8650
3. Wilde H., Briggs D.J., Meslin F.X., Hemachudha T., and Sitprija V. Rabies update for travel medicine advisors. Clin Infect Dis 37 (2003) 96-100
4. Strady A., Lang J., Lienard M., Blondeau C., Jaussaud R., and Plotkin S.A. Antibody persistence following pre-exposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis 177 (1998) 1290-1295
5. Smith J., Yager P.A., and Baer G.M. A rapid reproducible test for detection of rabies neutralizing antibodies. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory techniques in rabies. 4th ed. (1996), World Health Organziation, Geneva 181-192
6. Brown D., Featherstone J.J., Fooks A.R., Gettner S., Lloyd E., and Schweiger M. Intradermal pre-exposure rabies vaccine elicits long lasting immunity. Vaccine 26 (2008) 3909-3912
7. Suwansrinon K., Wilde H., Benjavongkulchai M., Banjongkasaena U., Lertjarutorn S., Boonchang S., et al. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Vaccine 24 (2006) 3878-3880
8. Shaw M.M., Leggat P.A., and Williams M.L. Intradermal pre-exposure rabies immunisation in New Zealand. Travel Med Infect Dis 4 (2006) 29-33
9. Hohler T., Reuss E., Evers N., Dietrich E., Rittner C., Freitag C.M., et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 360 (2002) 991-995
10. Hohler T., Reuss E., Freitag C.M., and Schneider P.M. A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology 42 (2005) 72-76
11. St Sauver J.L., Ovsyannikova I.G., Jacobson R.M., Jacobsen S.J., Vierkant R.A., Schaid D.J., et al. Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine. J Infect Dis 185 (2002) 1545-1549
12. Khawplod P., Wilde H., Benjavongkulchai M., Sriaroon C., and Chomchey P. Immunogenicity study of abbreviated rabies preexposure vaccination schedules. J Travel Med 14 (2007) 173-176
13. Ajjan N., and Pillet C. Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells. Vaccine 7 (1989) 125-128
14. Bernard K.W., Mallonee L., Wright J.C., Reid F.L., Makintubee S., Parker R.A., et al. Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination. JAMA 257 (1987) 1059-1063
15. Briggs D.J., Dreesen D.W., Nicolay U., Chin J.E., Davis R., Gordon C., et al. Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons. Vaccine 19 (2000) 1055-1060
16. Dreesen D.W., Fishbein D.B., Kemp D.T., and Brown J. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine 7 (1989) 397-400
17. Jaijaroensup W., Limusanno S., Khawplod P., Serikul K., Chomchay P., Kaewchomphoo W., et al. Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination. J Travel Med 6 (1999) 234-237
18. Rodrigues F.M., Mandke V.B., Roumiantzeff M., Rao C.V., Mehta J.M., Pavri K.M., et al. Persistence of rabies antibody 5 years after pre-exposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose. Epidemiol Infect 99 (1987) 91-95
19. Sabchareon A., Chantavanich P., Pasuralertsakul S., Pojjaroen-Anant C., Prarinyanupharb V., Attanath P., et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure Primary and booster immunizations with purified Vero cell rabies vaccine. Pediat Inf Dis J 17 (1998) 1001-1007
20. Vodopija R., Lafont M., Baklaic Z., Ljubicic M., Svjetlicic M., and Vodopija I. Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine. Vaccine 15 (1997) 571-574
21. Yang Y., and Zhang J. An experimental study on the endurance of immunologic memory of intradermal micro-injection with rabies vaccine and boosting immune effect. J Epidemiol 9 (1999) 209-215
22. Fishbein D.B., Bernard K.W., Miller K.D., Van der Vlugt T., Gains C.E., Bell J.T., et al. The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine. Am J Trop Med Hyg 35 (1986) 663-670
23. Kositprapa C., Limsuwun K., Wilde H., Jaijaroensup W., Saikasem A., Khawplod P., et al. Immune response to simulated post-exposure rabies booster vaccinations in volunteers who received preexposure vaccinations. Clin Infect Dis 25 (1997) 614-616
24. Picot N., Le Mener V., Rotivel Y., Schönfeld C., Cetre J.C., and Costy F. Booster effect of a new chromatographically purified Vero-cell rabies vaccine (CPRV): immunogenicity and safety of a single or double injection. Trans R Soc Trop Med Hyg 95 (2001) 342-344